Katherine Jeanne Swearingin, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 701 White Pond Dr Ste 100, Akron, OH 44320 Phone: 330-865-1252 Fax: 330-865-1260 |
Anna Brown, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-4440 Fax: 330-543-4467 |
Lauren Renae Fockler, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-1000 |
Kaitlin Minotti, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 701 White Pond Dr Ste 100, Akron, OH 44320 Phone: 330-865-1252 |
Ms. Kerry L Braucher, Pediatrics - Child Abuse Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 214 W Bowery St, Akron, OH 44308 Phone: 330-543-1000 |
Abubakr Abdelgalil Imam, MD Pediatrics - Pediatric Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-8950 Fax: 330-543-3980 |
Bradley Vansickle, MD, PHD Pediatrics - Pediatric Endocrinology Medicare: Medicare Enrolled Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-3276 Fax: 330-543-8489 |
Mr. Paul Benjamin Moore, MSN, APRN, CPNP Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-8050 Fax: 330-543-8054 |
Dr. Daniel David Tabaka, DO Pediatrics - Pediatric Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-8452 Fax: 330-543-3761 |
Robert L. Sobieski, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 300 Locust St, Suite 200, Akron, OH 44302 Phone: 330-253-7753 Fax: 330-253-4611 |
Jeffrey David Solomon, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-4440 Fax: 330-543-4467 |
Megan Charlotte Knowles, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-8530 Fax: 330-543-3731 |
Dr. Lindsay Kathleen Kahlenberg, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-1000 |
Michelle Nations Levitt, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-3276 Fax: 330-543-8489 |
Melisa A Carmichael, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 701 White Pond Dr Ste 100, Akron, OH 44320 Phone: 330-865-1252 Fax: 330-865-1260 |
Erin Nicole Wright, M.D. Pediatrics - Pediatric Hematology-Oncology Medicare: Medicare Enrolled Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-8580 |
Meghan Whitehouse Mahanta, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 701 White Pond Dr Ste 100, Akron, OH 44320 Phone: 330-865-1252 Fax: 330-865-1260 |
Mrs. Sandra Kay Bennett, CPNP-PC Pediatrics - Developmental – Behavioral Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-8050 Fax: 330-543-8054 |
Vanessa Marie Hormaza, M.D. Pediatrics - Pediatric Cardiology Medicare: Medicare Enrolled Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-8521 |
Caridad Martinez-kinder, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-8178 |
News Archive
LAM Pharmaceutical, a biomedical company focused on the development and commercialization of novel wound healing and transdermal drug delivery systems, announced today that the Chinese State Food and Drug Administration ("SFDA") has granted approval for the importation and sale of its patented LAM IPM Wound Gel(TM) in China
St. Jude Medical, Inc. has announced U.S. Food and Drug Administration (FDA) and European CE Mark approvals of EonC, the first extended-life primary cell (non-rechargeable) neurostimulator for the treatment of chronic pain.
Gilead Sciences, Inc. today announced receipt of a Paragraph IV Certification Notice Letter advising that Lupin Limited submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) requesting permission to manufacture and market a generic version of Ranexa® (ranolazine extended-release tablets).
CyDex Pharmaceuticals, Inc., a specialty pharmaceutical company, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a patent to the company entitled "Sulfoalkyl Ether Cyclodextrin Compositions and Methods of Preparation Thereof." This patent, along with other previously issued technology patents, will provide broader protection for CyDex's Captisol® technology until 2028.
Migraine with aura was associated with an increased risk of ischemic stroke in the Atherosclerosis Risk in Communities study, but a recent post-hoc analysis published in Headache reveals unexpected results suggesting that onset of such migraines before age 50 years is not associated with such risk.
› Verified 8 days ago